National HealthCare Corp (NHC) shareholders
Close on Nov 17, 2026Market cap $3.22BP/E 23.1Yield 1.23%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 1,800,345 | 11.60% | 13G (passive) amendment | Sep 30, 2025 |
| Morgan Stanley Joint filing with Morgan Stanley Institutional Investment Advisors LLC (6.70%) | 1,102,537 | 7.10% | 13G (passive) amendment | Dec 31, 2025 |
| Dimensional Fund Advisors LP | 957,815 | 6.30% | 13G (passive) amendment | Dec 29, 2023 |
| First Trust Portfolios L.P. Joint filing with First Trust Advisors L.P. (5.09%), The Charger Corporation (5.09%) | 795,771 | 5.09% | 13G (passive) | Jun 30, 2026 |
| Vanguard Portfolio Management | 794,305 | 5.11% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,975,785 | 12.62% | $417.60M | +80,535 | 0.01% |
| Morgan Stanley Institutional Investment Advisors LLC | 1,028,534 | 6.57% | $217.39M | −10,270 | 20.31% |
| Dimensional Fund Advisors LP | 929,692 | 5.94% | $196.49M | −17,285 | 0.04% |
| Vanguard Portfolio Management LLC | 809,224 | 5.17% | $171.04M | +19,803 | 0.01% |
| First Trust Advisors LP | 730,573 | 4.66% | $154.41M | +200,271 | 0.09% |
| Vanguard Capital Management LLC | 552,136 | 3.53% | $116.70M | +2,588 | 0.00% |
| State Street Corp | 526,732 | 3.36% | $111.68M | +35,157 | 0.00% |
| Geode Capital Management, LLC | 380,934 | 2.43% | $80.53M | +57,667 | 0.00% |
| Renaissance Technologies LLC | 299,717 | 1.91% | $63.35M | −35,800 | 0.09% |
| Invesco Ltd. | 175,290 | 1.12% | $37.05M | +25,094 | 0.00% |
| Charles Schwab Investment Management Inc | 174,335 | 1.11% | $36.85M | −4,263 | 0.00% |
| Northern Trust Corp | 145,179 | 0.93% | $30.69M | +8,468 | 0.00% |
| Bank of New York Mellon Corp | 122,320 | 0.78% | $25.85M | +2,367 | 0.00% |
| Systematic Financial Management LP | 109,086 | 0.70% | $23.06M | −7,162 | 0.46% |
| T. Rowe Price Investment Management, Inc. | 107,248 | 0.68% | $22.67M | New | 0.01% |
| Arrowstreet Capital, Limited Partnership | 96,550 | 0.62% | $20.41M | +21,293 | 0.01% |
| Morgan Stanley | 93,536 | 0.60% | $19.77M | −14,276 | 0.00% |
| American Century Companies Inc | 92,933 | 0.59% | $19.64M | +3,317 | 0.01% |
| Alps Advisors Inc | 87,660 | 0.56% | $18.53M | −70,180 | 0.09% |
| Vanguard Fiduciary Trust Co | 84,971 | 0.54% | $17.96M | +4,802 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 248 | 10M | 65.3% | 39 / 93 | 75 / 26 | 1M | 1M |
| Q1 2026 | 239 | 10M | 66.1% | 45 / 76 | 77 / 23 | 2M | 0M |
| Q4 2025 | 222 | 10M | 63.8% | 34 / 74 | 77 / 17 | 1M | 0M |
| Q3 2025 | 207 | 10M | 61.3% | 38 / 61 | 72 / 21 | 1M | 0M |
| Q2 2025 | 190 | 9M | 57.5% | 32 / 63 | 65 / 19 | 0M | 0M |
| Q1 2025 | 179 | 9M | 57.9% | 20 / 64 | 68 / 23 | 0M | 1M |
| Q4 2024 | 185 | 9M | 58.6% | 19 / 62 | 72 / 28 | 0M | 0M |
| Q3 2024 | 194 | 9M | 59.4% | 35 / 62 | 66 / 14 | 3M | 0M |
| Q2 2024 | 175 | 8M | 54.2% | 25 / 60 | 66 / 19 | 0M | 0M |
| Q1 2024 | 170 | 9M | 55.0% | 31 / 42 | 70 / 20 | 1M | 1M |
| Q4 2023 | 159 | 9M | 56.7% | 40 / 47 | 57 / 11 | 2M | 1M |
| Q3 2023 | 131 | 7M | 47.0% | 11 / 41 | 55 / 12 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
271 funds held NHC in Q2 2026, 62% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 752,952 | 4.81% | $159.14M | 0.14% | Jun 30, 2026 |
| First Trust SMID Cap Rising Dividend Achievers ETF | 636,492 | 4.06% | $134.53M | 1.19% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 396,172 | 2.53% | $83.73M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 333,531 | 2.13% | $70.50M | 0.08% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 286,336 | 1.83% | $60.52M | 0.03% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 193,388 | 1.23% | $43.71M | 0.22% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 181,535 | 1.16% | $38.37M | 0.06% | Jun 30, 2026 |
| ALPS | OShares U.S. Small-Cap Quality Dividend ETF | 153,397 | 0.98% | $28.29M | 3.23% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 143,030 | 0.91% | $30.23M | 0.03% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 142,177 | 0.91% | $32.14M | 0.09% | Jul 31, 2026 |
| U.S. Targeted Value Portfolio | 128,627 | 0.82% | $29.07M | 0.17% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 115,008 | 0.73% | $24.31M | 0.14% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 112,293 | 0.72% | $23.73M | 0.29% | Jun 30, 2026 |
| Invesco S&P SmallCap Momentum ETF | 111,575 | 0.71% | $25.22M | 0.83% | Jul 31, 2026 |
| Dimensional U.S. Targeted Value ETF | 93,924 | 0.60% | $21.23M | 0.15% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Stephen Fowler Flatt | CEO, Director | 65,487 | 0.42% | Aug 20, 2026 |
| Vicki L. Dodson | Sr.VP Patient Srvcs | 10,726 | 0.07% | Sep 23, 2026 |
| Josh A. McCreary | Senior VP & General Counsel | 9,979 | 0.06% | Sep 14, 2026 |
| Brian F. Kidd | SVP, CFO | 23,183 | 0.15% | Sep 14, 2026 |
| Ben Anderson Flatt Sr | Senior VP & CIO | 15,636 | 0.10% | Sep 2, 2026 |
| Timothy J. Shelly | Sr.VP Operations | 1,294 | 0.01% | May 20, 2026 |
| Robert Michael Ussery | President & COO | 158,460 | 1.01% | Jan 5, 2026 |
| David R. Gifford | Director | 1,030 | 0.01% | Aug 28, 2026 |
| Emil E. Hassan | Director | 65,595 | 0.42% | Jun 23, 2026 |
| Robert G. Adams | Director | 443,920 | 2.83% | Jun 10, 2026 |
| Lisa Piercey | Director | 949 | 0.01% | Jun 2, 2026 |
| Richard F. Laroche Jr | Director | 301,760 | 1.93% | May 22, 2026 |
| Sandra Y. Trail | Director | 10,640 | 0.07% | May 8, 2026 |
| William A. Adams | Director | – | – | May 8, 2026 |
| James Paul Abernathy | Director | 43,302 | 0.28% | May 7, 2026 |
| W. Andrew Adams | Director | 304,979 | 1.95% | May 6, 2025 |
| Health Corp National | – | 1,030,887 | 6.58% | Jan 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Vicki L. Dodson Sr.VP Patient Srvcs | Sep 22, 2026 | Sale | −4,834 | $225.00 | $1.09M | 10,726 |
| Brian F. Kidd SVP, CFO | Sep 11, 2026 | Sale | −6,813 | $225.70 | $1.54M | 23,183 |
| Josh A. McCreary Senior VP & General Counsel | Sep 10, 2026 | Sale | −68 | $225.59 | $15.34K | 9,979 |
| Josh A. McCreary Senior VP & General Counsel | Sep 10, 2026 | Sale | −571 | $222.73 | $127.18K | 12,127 |
| Josh A. McCreary Senior VP & General Counsel | Sep 10, 2026 | Sale | −789 | $223.78 | $176.56K | 11,338 |
| Josh A. McCreary Senior VP & General Counsel | Sep 10, 2026 | Sale | −1,291 | $225.09 | $290.59K | 10,047 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 28, 2026 | Sale | −1,000 | $222.50 | $222.50K | 15,636 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 25, 2026 | Sale | −1,000 | $227.00 | $227.00K | 16,636 |
| David R. Gifford Director | Aug 25, 2026 | Sale | −1,779 | $225.42 | $401.02K | 1,030 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 20, 2026 | Sale | −1,000 | $237.00 | $237.00K | 17,636 |
| David R. Gifford Director | Aug 20, 2026 | Option exercise | +6,479 | $171.42 | $1.11M | 7,500 |
| David R. Gifford Director | Aug 20, 2026 | Award | −4,691 | $236.75 | $1.11M | 2,809 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 19, 2026 | Sale | −1,000 | $237.18 | $237.18K | 18,636 |
| Stephen Fowler Flatt CEO, Director | Aug 19, 2026 | Sale | −1,500 | $237.08 | $355.62K | 65,487 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 17, 2026 | Sale | −1,000 | $226.00 | $226.00K | 19,636 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 14, 2026 | Sale | −1,000 | $222.11 | $222.11K | 20,636 |
| David R. Gifford Director | Aug 13, 2026 | Option exercise | +1,021 | $171.42 | $175.02K | 1,021 |
| Ben Anderson Flatt Sr Senior VP & CIO | Aug 12, 2026 | Sale | −1,000 | $221.21 | $221.21K | 21,636 |
| Emil E. Hassan Director | Jun 22, 2026 | Sale | −5,937 | $200.00 | $1.19M | 65,595 |
| Emil E. Hassan Director | Jun 16, 2026 | Sale | −1,563 | $199.98 | $312.57K | 71,532 |
| Brian F. Kidd SVP, CFO | Jun 16, 2026 | Gift | −500 | – | – | 29,996 |
| Robert G. Adams Director | Jun 8, 2026 | Gift | −4,000 | – | – | 13,579 |
| Robert G. Adams Director | Jun 8, 2026 | Option exercise | +4,000 | $69.19 | $276.76K | 17,579 |
| Lisa Piercey Director | Jun 1, 2026 | Buy | +949 | $184.26 | $174.86K | 949 |
| Ben Anderson Flatt Sr Senior VP & CIO | May 22, 2026 | Option exercise | +4,000 | $94.10 | $376.40K | 25,375 |
| Ben Anderson Flatt Sr Senior VP & CIO | May 22, 2026 | Tax withholding | −2,739 | $196.00 | $536.84K | 22,636 |
| Richard F. Laroche Jr Director | May 21, 2026 | Sale | −7,500 | $195.14 | $1.46M | 205,760 |
| Stephen Fowler Flatt CEO, Director | May 20, 2026 | Gift | −26 | – | – | 66,987 |
| Timothy J. Shelly Sr.VP Operations | May 19, 2026 | Sale | −1,853 | $197.22 | $365.45K | 1,294 |
| Stephen Fowler Flatt CEO, Director | May 14, 2026 | Tax withholding | −4,492 | $197.96 | $889.24K | 67,013 |
| Stephen Fowler Flatt CEO, Director | May 14, 2026 | Option exercise | +1,000 | $90.62 | $90.62K | 71,505 |
| Stephen Fowler Flatt CEO, Director | May 14, 2026 | Option exercise | +5,000 | $94.10 | $470.50K | 70,505 |
| Brian F. Kidd SVP, CFO | May 14, 2026 | Tax withholding | −3,134 | $197.96 | $620.41K | 30,496 |
| Brian F. Kidd SVP, CFO | May 14, 2026 | Option exercise | +500 | $90.62 | $45.31K | 33,630 |
| Brian F. Kidd SVP, CFO | May 14, 2026 | Option exercise | +4,000 | $94.10 | $376.40K | 33,130 |
| Sandra Y. Trail Director | May 6, 2026 | Option exercise | +3,140 | $55.75 | $175.06K | 10,640 |
| Richard F. Laroche Jr Director | May 5, 2026 | Option exercise | +7,500 | $71.64 | $537.30K | 213,260 |
| Emil E. Hassan Director | Apr 30, 2026 | Option exercise | +7,500 | $71.64 | $537.30K | 73,095 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Apr 22, 2026 | Option exercise | +4,000 | $94.10 | $376.40K | 18,413 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Apr 22, 2026 | Tax withholding | −2,853 | $173.63 | $495.37K | 15,560 |
| Ben Anderson Flatt Sr Senior VP & CIO | Apr 9, 2026 | Tax withholding | −2,109 | $176.81 | $372.89K | 21,175 |
| Ben Anderson Flatt Sr Senior VP & CIO | Apr 9, 2026 | Tax withholding | −1,909 | $176.81 | $337.53K | 21,375 |
| Ben Anderson Flatt Sr Senior VP & CIO | Apr 9, 2026 | Option exercise | +3,734 | $53.94 | $201.41K | 23,284 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Mar 16, 2026 | Tax withholding | −2,034 | $164.96 | $335.53K | 14,413 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Mar 16, 2026 | Option exercise | +3,734 | $53.94 | $201.41K | 16,447 |
| Brian F. Kidd SVP, CFO | Mar 12, 2026 | Option exercise | +1,853 | $53.94 | $99.95K | 29,130 |
| Stephen Fowler Flatt CEO, Director | Mar 12, 2026 | Option exercise | +1,853 | $53.94 | $99.95K | 65,505 |
| James Paul Abernathy Director | Mar 9, 2026 | Option exercise | +3,140 | $55.75 | $175.06K | 43,302 |
| Josh A. McCreary Senior VP & General Counsel | Mar 4, 2026 | Tax withholding | −3,202 | $172.83 | $553.40K | 12,698 |
| Josh A. McCreary Senior VP & General Counsel | Mar 4, 2026 | Option exercise | +4,500 | $90.62 | $407.79K | 15,900 |
| Timothy J. Shelly Sr.VP Operations | Mar 4, 2026 | Option exercise | +3,667 | $90.62 | $332.30K | 7,628 |
| Timothy J. Shelly Sr.VP Operations | Mar 4, 2026 | Option exercise | +2,667 | $94.10 | $250.96K | 3,961 |
| Timothy J. Shelly Sr.VP Operations | Mar 4, 2026 | Tax withholding | −4,481 | $172.83 | $774.45K | 3,147 |
| Brian F. Kidd SVP, CFO | Mar 4, 2026 | Tax withholding | −3,947 | $172.83 | $682.16K | 27,277 |
| Brian F. Kidd SVP, CFO | Mar 4, 2026 | Option exercise | +2,000 | $53.94 | $107.88K | 27,224 |
| Brian F. Kidd SVP, CFO | Mar 4, 2026 | Option exercise | +4,000 | $90.62 | $362.48K | 31,224 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Mar 4, 2026 | Option exercise | +4,500 | $90.62 | $407.79K | 15,872 |
| Vicki L. Dodson Sr.VP Patient Srvcs | Mar 4, 2026 | Tax withholding | −3,159 | $172.83 | $545.97K | 12,713 |
| Ben Anderson Flatt Sr Senior VP & CIO | Mar 4, 2026 | Tax withholding | −8,142 | $172.83 | $1.41M | 19,550 |
| Ben Anderson Flatt Sr Senior VP & CIO | Mar 4, 2026 | Option exercise | +4,500 | $90.62 | $407.79K | 27,692 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of National HealthCare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,258 shares on Sep 28, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Josh A. McCreary Officer | Sep 10, 2026 | 2,719 | $600.82K | Sep 10, 2026 | Restricted Stock Vesting |
| Richard F. Laroche Jr Director | May 21, 2026 | 7,500 | $1.46M | May 21, 2026 | Options Exercise |
| National Health Corporation (NHC) Affiliate | Dec 27, 2024 | 55,000 | $6.11M | Dec 20, 2024 | Corporate Restructuring |
| James Paul Abernathy Director | Aug 13, 2024 | 1,605 | $195.81K | Aug 13, 2024 | Stock Option Grant of 6-2-10 |
| James Paul Abernathy Director | Aug 4, 2023 | 1,550 | $92.66K | Aug 14, 2023 | Exercise Stock Option, Granted 6/2/2016 |
See a number that looks wrong?